Showing results (1291-1300 of 1,407) with videos related to
Sort By:
Pageof 141
Pharmacology Research & Perspectives|December 16, 2014
Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synucleinIddo Magen, Regina Ostritsky, Franziska Richter, et al.Pharmacology Research & Perspectives|December 16, 2014
Isobenzofuranone derivatives exhibit antileishmanial effect by inhibiting type II DNA topoisomerase and inducing host responseAmartya Mishra, Jayaraman Vinayagam, Sourav Saha, et al.Pharmacology Research & Perspectives|December 16, 2014
Development of a 'patient information leaflet' for use following assessment of patients with reported or suspected paracetamol overdose in the UKThomas Potter, Wui Ling Chan, John R H Archer, et al.Pharmacology Research & Perspectives|December 16, 2014
Selective IAP inhibition results in sensitization of unstimulated but not CD40-stimulated chronic lymphocytic leukaemia cells to TRAIL-induced apoptosisJianguo Zhuang, Naomi Laing, Melanie Oates, et al.Pharmacology Research & Perspectives|August 4, 2015
The discovery of a selective and potent A2a agonist with extended lung retentionAnnika B M Åstrand, Eva Lamm Bergström, Hui Zhang, et al.Pharmacology Research & Perspectives|August 4, 2015
Replication - why we need to publish our findingsMichael J Curtis, Darrell R AbernethyPharmacology Research & Perspectives|December 12, 2017
Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell modelsYuanyuan Zhang, Carl LaCerte, Sanjay Kansra, et al.Pharmacology Research & Perspectives|December 12, 2017
PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase-1 by a mechanism dependent on MAP kinase phosphatase-1Lauri Tuure, Mari Hämäläinen, Eeva MoilanenPharmacology Research & Perspectives|December 12, 2017
Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteersKathleen Weisel, Nicola E Scott, Debra J Tompson, et al.Pharmacology Research & Perspectives|February 9, 2018
Safety signal detection and evaluation in clinical development programs: A case study of tofacitinibGorana Dasic, Thomas Jones, Vera Frajzyngier, et al.Pageof 141